Navigation Links
PIP in Biological Technology

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

... ANNAPOLIS, Md., Aug. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it ...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

... ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Admini...

PharmAthene Reports First Quarter 2009 Financial and Operational Results

... ANNAPOLIS, Md., May 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...

PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast

... ANNAPOLIS, Md., May 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced a date change for its first quarter 2009 ...

PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009

... ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

... ANNAPOLIS, Md., April 28 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that results from a second Phase I...

PharmAthene Announces $5.5 Million Public Equity Offering

... ANNAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that certain institutional investo...

PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009

... ANNAPOLIS, Md., March 19 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting

...atric Investigation Plan (PIP) Advisory from PAREXEL Consulting, with an update and guidance on how biopharmaceutical companies should address the new pip requirements, will be provided at PAREXEL's Booth #1522 . PAREXEL experts will also be available at the booth to hold exclusive executive briefings w...

PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008

... ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)

...ANNAPOLIS, Md., Oct. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ), a leading monoclonal antibody company, and PharmAthene, Inc. (NYSE: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced results from a pilot study showing...

PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases

...acea Biotec to Make a $13.1 Million Strategic Investment in PharmAthene ANNAPOLIS, Md., Sept. 30 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has entered into a strateg...

PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program

... ANNAPOLIS, Md., Sept. 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the National Institute of All...

PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008

... ANNAPOLIS, Md., Sept. 18 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will present two ...

PharmAthene to Present at the UBS Global Life Sciences Conference on Thursday September 25, 2008

... ANNAPOLIS, Md., Sept. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and...

PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration

... ANNAPOLIS, Md., Sept. 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, annou...

PharmAthene Reports Second Quarter 2008 Financial and Operational Results

... On Track to Reach Significant Milestones in Second Half 2008 ANNAPOLIS, Md., Aug. 12 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...

Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene

...ies for the Company's Medical Countermeasures ANNAPOLIS, Md., Aug. 11 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that Lord Lewis Moonie has joined ...

PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel

...ANNAPOLIS, Md., July 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company specializing in the development and commercializatio...sion into broader markets." About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Reports First Quarter 2008 Financial Results

... ANNAPOLIS, Md., May 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica..., or until June 13, 2008. About PharmAthene, Inc. PharmAthene's (Amex: pip ) mission is to be the premier company worldwide specializing in the develo...

PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008

... ANNAPOLIS, Md., May 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...pproximately June 13, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed in March 2001 with a mission to become the premier company wor...

PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit

...IS, Md., April 2, 2008 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company specializing in the development and commercializatio...e against anthrax threats." About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Reports Year-End 2007 Financial Results

...NNAPOLIS, Md., March 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...proximately April 30, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program

...NAPOLIS, Md., March 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company specializing in the development and commercializatio...hich are exceedingly toxic. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008

...NAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica...ys, or until April 30, 2008. About PharmAthene, Inc PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene to Delay Release of Full Year 2007 Financial Results

...NNAPOLIS, Md., March 20 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...on announced earlier today. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia

...e website. The webcast will be available for 30 days, or until approximately Thursday, April 17, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference

...NAPOLIS, Md., March 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... Jurchison at 410-269-2610. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008

...sified as either G-agents (sarin, soman, tabun) or V-agents (VX), both of which are exceedingly toxic. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations

...aduate of the University of Pittsburgh where she received a Ph.D. in Microbiology/Biological Sciences. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene to Present at the BIO CEO & Investor Conference 2008

...ANNAPOLIS, Md., Feb. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... Jurchison at 410-269-2610. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthene's Legal Action in Breach of Contract Lawsuit Against SIGA

...NNAPOLIS, Md., Jan. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... the treatment of smallpox. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services

...NNAPOLIS, Md., Sept. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company specializing in the development and commercializati...ecuted agreement is received. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its Allies...

Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court

... ANNAPOLIS, Md., Aug. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing and commercializing medical countermeasures against biological and chemical threats, announced today that proceeding...

Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.

... ANNAPOLIS, Md., Aug. 17 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) announced today that a hearing has been scheduled by the Delaware Court of Chancery for 2:00 p.m. on Monday, August 27, 2007, in an action filed by ...

Technology changing for better, Coburn says

... Madison, Wis. - pip Coburn offers a different framework for selling products to what he calls, in a tongue-in-cheek manner, "real humans." And given his forecasting credi...
Other Tags
(Date:10/30/2014)... NY, October 30, 2014—Oligonucleotide-based therapeutics present unique challenges ... cause reproductive and developmental harm. New consensus guidelines ... combined chemical and biological characteristics of these novel ... , a peer-reviewed journal from Mary Ann ... free on the Nucleic Acid Therapeutics ...
(Date:10/30/2014)... | Heidelberg, 30 October 2014 Biological membranes are ... understanding of adsorption of solution ions onto lipid ... Now, a new study provides a quantitative description ... solution ions. Joanna Kotyńska and Zbigniew Figaszewski from ... of a study describing these findings, just published ...
(Date:10/29/2014)... their hair as a consequence of chemotherapy will benefit ... scalp cooling technology that prevents hair loss. , The ... by global scalp cooling manufacturing company, Paxman Coolers, of ... of the University of Huddersfield. , The research will ... a background in the pharmacology of cancer treatment, which ...
Breaking Biology News(10 mins):New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2Ion adsorption matter in biology 2New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2
(Date:10/30/2014)... by NIH grantees predicts that women must take the ... vaginal sex, whereas just two doses per week can ... finding helps explain why two large clinical trials testing ... show efficacy. Participants in the VOICE and ... antiretroviral) for HIV prevention were counseled to take one ...
(Date:10/30/2014)... Pompano Beach, Florida (PRWEB) October 30, 2014 ... surprise Halloween visit to Pompano Beach firefighters, showing that ... your community. , Timothy met firefighters Tracey and ... sponsored by Galuppi’s Restaurant and the Pompano Beach Chamber ... and outside the fire truck, letting Timothy wear his ...
(Date:10/30/2014)... NC (PRWEB) October 30, 2014 Don ... commercial, and health insurance plans for North Carolina residents, ... satellite office in Burlington’s Holly Hill Mall. The new ... with agents already helping customers through all facets of ... purchase. , Allred Insurance spokesman Scott Allred couldn’t be ...
(Date:10/30/2014)... 2014 Five months after their expansion, ... LLC announces new branding and a website to accompany ... After David Mepham’s promotion to name partner earlier this ... to include Mepham’s name and better reflect their combined ... firm, the decision to implement new branding reflects Hodgkinson ...
(Date:10/30/2014)... 30, 2014 Paramount Rx, a full-service ... increasing efforts to help people save money through its ... increase for prescription drugs in the new health care ... resources to bridge the relationship between consumers, businesses and ... biggest challenges people face today with medical costs is ...
Breaking Medicine News(10 mins):Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:Allred Insurance Satellite Office Grand Opening 2Health News:Hodgkinson Street Mepham Rebrands 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3
Other Contents